Early Tumor Shrinkage (Ets) And Depth Of Response (Dpr) In Wild-Type (Wt) Ras Tumors From The Phase Iii Trial Of Panitumumab (Pmab) Plus Best Supportive Care (Bsc) Versus Bsc In Chemorefractory Metastatic Colorectal Cancer (Mcrc).